• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000.

作者信息

Vieira João, Marcelino João, Ferreira Fátima, Farinha Sofia, Silva Rita, Proença Miguel, Tomaz Elza

机构信息

Immunoallergology Department, Centro Hospitalar de Setúbal EPE, Setúbal, Portugal.

出版信息

Asia Pac Allergy. 2021 Apr 26;11(2):e18. doi: 10.5415/apallergy.2021.11.e18. eCollection 2021 Apr.

DOI:10.5415/apallergy.2021.11.e18
PMID:34007828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8103012/
Abstract
摘要

相似文献

1
Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000.使用辉瑞新冠病毒疫苗和聚乙二醇2000进行皮肤试验。
Asia Pac Allergy. 2021 Apr 26;11(2):e18. doi: 10.5415/apallergy.2021.11.e18. eCollection 2021 Apr.
2
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
3
Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).意大利那不勒斯“帕斯卡尔基金会”癌症中心（INT - IRCCS）医护人员的疫苗接种策略及抗SARS-CoV-2 S抗体滴度
Infect Agent Cancer. 2021 May 12;16(1):32. doi: 10.1186/s13027-021-00375-2.
4
Antibody responses boosted in seropositive healthcare workers after single dose of SARS-CoV-2 mRNA vaccine.单剂新冠病毒mRNA疫苗接种后，血清阳性医护人员的抗体反应增强。
medRxiv. 2021 Feb 5:2021.02.03.21251078. doi: 10.1101/2021.02.03.21251078.
5
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.免疫实践咨询委员会关于使用辉瑞-BioNTech COVID-19 疫苗的临时建议-美国，2020 年 12 月。
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922-1924. doi: 10.15585/mmwr.mm6950e2.
6
PEG skin testing for COVID-19 vaccine allergy.用于新冠疫苗过敏的聚乙二醇皮肤试验
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1765. doi: 10.1016/j.jaip.2021.02.016.
7
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Neonatal Cord Blood After Vaccination in Pregnancy.孕期接种疫苗后新生儿脐带血中的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体
Obstet Gynecol. 2021 May 1;137(5):894-896. doi: 10.1097/AOG.0000000000004367.
8
[Current state of vaccination against SARS-CoV-2].[新型冠状病毒2型（SARS-CoV-2）疫苗接种的现状]
Z Rheumatol. 2021 Mar;80(2):158-164. doi: 10.1007/s00393-021-00966-9. Epub 2021 Feb 2.
9
Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.刺突蛋白在 Sars-CoV-2 疫苗设计中的结构域和功能。
Viruses. 2021 Jan 14;13(1):109. doi: 10.3390/v13010109.
10
COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.新型冠状病毒肺炎（COVID-19）mRNA 疫苗（辉瑞-生物科技和 Moderna）在多发性硬化症患者中的应用：波兰神经病学会多发性硬化症和神经免疫学分会召集的工作组的一份声明。
Neurol Neurochir Pol. 2021;55(1):8-11. doi: 10.5603/PJNNS.a2021.0016. Epub 2021 Feb 8.

引用本文的文献

1
Study of Excipients in Delayed Skin Reactions to mRNA Vaccines: Positive Delayed Intradermal Reactions to Polyethylene Glycol Provide New Insights for COVID-19 Arm.mRNA疫苗延迟皮肤反应中辅料的研究：对聚乙二醇的阳性延迟皮内反应为新冠疫苗接种部位反应提供新见解
Vaccines (Basel). 2022 Nov 30;10(12):2048. doi: 10.3390/vaccines10122048.
2
PEG allergy - A COVID-19 pandemic-made problem? A German perspective.聚乙二醇过敏——新冠疫情引发的问题？德国视角。
World Allergy Organ J. 2022 Nov;15(11):100714. doi: 10.1016/j.waojou.2022.100714. Epub 2022 Oct 31.
3
A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination.一项针对 COVID-19 疫苗接种后死亡的尸检方法的系统回顾和建议。
Forensic Sci Int. 2022 Nov;340:111469. doi: 10.1016/j.forsciint.2022.111469. Epub 2022 Sep 20.
4
Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies.新型冠状病毒肺炎疫苗引起的速发型超敏反应：当前趋势、潜在机制及预防策略
Biomedicines. 2022 May 28;10(6):1260. doi: 10.3390/biomedicines10061260.
5
Allergological study in patients vaccinated against COVID-19 with suspected allergic reactions.对接种新冠疫苗后出现疑似过敏反应患者的变态反应学研究。
Allergy Asthma Clin Immunol. 2022 May 27;18(1):43. doi: 10.1186/s13223-022-00685-z.
6
Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis.新型冠状病毒2型疫苗的过敏反应和非过敏反应：一项系统评价与荟萃分析
Allergy Asthma Clin Immunol. 2021 Oct 16;17(1):109. doi: 10.1186/s13223-021-00613-7.
7
Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase.BNT162b2 mRNA（辉瑞-生物科技）COVID-19 疫苗在有急性淋巴细胞白血病病史和对聚乙二醇-天冬酰胺酶过敏的青少年和年轻人中的使用安全性。
Pediatr Blood Cancer. 2021 Nov;68(11):e29295. doi: 10.1002/pbc.29295. Epub 2021 Aug 16.
8
Cough, coronavirus disease 2019, the vaccines, and allergy.咳嗽、2019冠状病毒病、疫苗与过敏。
Asia Pac Allergy. 2021 Apr 30;11(2):e23. doi: 10.5415/apallergy.2021.11.e23. eCollection 2021 Apr.

本文引用的文献

1
Nonirritant concentrations for skin testing with SARS-CoV-2 mRNA vaccine.用于新型冠状病毒2型信使核糖核酸疫苗皮肤试验的无刺激性浓度。
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2476-2477. doi: 10.1016/j.jaip.2021.03.022. Epub 2021 Mar 23.
2
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.2020年12月14日至2021年1月18日美国接种mRNA新冠疫苗后发生过敏反应的报告
JAMA. 2021 Mar 16;325(11):1101-1102. doi: 10.1001/jama.2021.1967.
3
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee.新型冠状病毒肺炎疫苗相关过敏反应：世界过敏组织过敏反应委员会声明
World Allergy Organ J. 2021 Feb;14(2):100517. doi: 10.1016/j.waojou.2021.100517. Epub 2021 Feb 3.
4
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.欧洲过敏与临床免疫学会关于严重 COVID-19 疫苗过敏反应的诊断、管理和预防的声明
Allergy. 2021 Jun;76(6):1629-1639. doi: 10.1111/all.14739.
5
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.mRNA 疫苗预防 COVID-19 疾病和报告的过敏反应：当前证据和建议方法。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437. doi: 10.1016/j.jaip.2020.12.047. Epub 2020 Dec 31.
6
Maintaining Safety with SARS-CoV-2 Vaccines.通过新冠病毒疫苗维持安全性。
N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.
7
Risk of anaphylaxis after vaccination in children and adults.儿童和成人接种疫苗后发生过敏反应的风险。
J Allergy Clin Immunol. 2016 Mar;137(3):868-78. doi: 10.1016/j.jaci.2015.07.048. Epub 2015 Oct 6.